25 XP   0   0   10

Biotech Medics Ne
Buy, Hold or Sell?

Let's analyse Biotech Medics Ne together

PenkeI guess you are interested in Biotech Medics Ne. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotech Medics Ne. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biotech Medics Ne

I send you an email if I find something interesting about Biotech Medics Ne.

Quick analysis of Biotech Medics Ne (30 sec.)










What can you expect buying and holding a share of Biotech Medics Ne? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.49
Expected worth in 1 year
$1.08
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$0.59
Return On Investment
3,293.9%

For what price can you sell your share?

Current Price per Share
$0.02
Expected price per share
$0.01 - $0.03
How sure are you?
50%

1. Valuation of Biotech Medics Ne (5 min.)




Live pricePrice per Share (EOD)

$0.02

Intrinsic Value Per Share

$0.00 - $0.05

Total Value Per Share

$0.49 - $0.54

2. Growth of Biotech Medics Ne (5 min.)




Is Biotech Medics Ne growing?

Current yearPrevious yearGrowGrow %
How rich?$99.5m$69.5m$29.9m30.1%

How much money is Biotech Medics Ne making?

Current yearPrevious yearGrowGrow %
Making money-$5.6k-$115.1k$109.5k1,947.4%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Biotech Medics Ne (5 min.)




What can you expect buying and holding a share of Biotech Medics Ne? (5 min.)

Welcome investor! Biotech Medics Ne's management wants to use your money to grow the business. In return you get a share of Biotech Medics Ne.

What can you expect buying and holding a share of Biotech Medics Ne?

First you should know what it really means to hold a share of Biotech Medics Ne. And how you can make/lose money.

Speculation

The Price per Share of Biotech Medics Ne is $0.018. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotech Medics Ne.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotech Medics Ne, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.49. Based on the TTM, the Book Value Change Per Share is $0.15 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotech Medics Ne.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.2%0.00-0.2%0.00-3.2%0.00-3.4%0.00-9.6%
Usd Book Value Change Per Share0.15823.5%0.15823.5%0.00-2.7%0.10547.0%0.06331.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.15823.5%0.15823.5%0.00-2.7%0.10547.0%0.06331.2%
Usd Price Per Share0.04-0.04-0.01-0.03-0.02-
Price to Earnings Ratio-1,291.71--1,291.71--14.41--278.86--184.74-
Price-to-Total Gains Ratio0.24-0.24--16.99--14.53-135,142.27-
Price to Book Ratio0.07-0.07-0.02--5.29--3.87-
Price-to-Total Gains Ratio0.24-0.24--16.99--14.53-135,142.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.018
Number of shares55555
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.150.10
Usd Total Gains Per Share0.150.10
Gains per Quarter (55555 shares)8,234.685,469.62
Gains per Year (55555 shares)32,938.7121,878.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10329393292902187821868
20658776586804375743746
30988169880706563565624
4013175513174608751487502
501646941646850109392109380
601976321976240131271131258
702305712305630153149153136
802635102635020175028175014
902964482964410196906196892
1003293873293800218785218770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.010.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.05.00.037.5%5.05.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.010.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.05.00.037.5%5.05.00.050.0%

Fundamentals of Biotech Medics Ne

About Biotech Medics Ne

BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.

Fundamental data was last updated by Penke on 2024-05-14 16:13:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Biotech Medics Ne.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biotech Medics Ne earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biotech Medics Ne to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotech Medics Ne:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.1.2. Return on Assets

Shows how efficient Biotech Medics Ne is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotech Medics Ne to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Assets means that Biotech Medics Ne generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotech Medics Ne:

  • The MRQ is 0.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.0%0.0%
TTM0.0%YOY-0.2%+0.2%
TTM0.0%5Y-6,248.4%+6,248.4%
5Y-6,248.4%10Y-9,145.3%+2,896.9%
1.1.3. Return on Equity

Shows how efficient Biotech Medics Ne is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotech Medics Ne to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Biotech Medics Ne generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotech Medics Ne:

  • The MRQ is 0.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.0%0.0%
TTM0.0%YOY-0.2%+0.2%
TTM0.0%5Y-0.1%+0.1%
5Y-0.1%10Y-15.2%+15.1%

1.2. Operating Efficiency of Biotech Medics Ne.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biotech Medics Ne is operating .

  • Measures how much profit Biotech Medics Ne makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotech Medics Ne to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotech Medics Ne:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Biotech Medics Ne is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biotech Medics Ne:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000

1.3. Liquidity of Biotech Medics Ne.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biotech Medics Ne is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotech Medics Ne:

  • The MRQ is 0.000. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.000. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.000TTM0.0000.000
TTM0.000YOY-+0.000
TTM0.0005Y0.000+0.001
5Y0.00010Y0.0000.000
1.3.2. Quick Ratio

Measures if Biotech Medics Ne is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotech Medics Ne to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotech Medics Ne:

  • The MRQ is 0.000. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.000. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.000TTM0.0000.000
TTM0.000YOY-+0.000
TTM0.0005Y0.000+0.001
5Y0.00010Y0.0000.000

1.4. Solvency of Biotech Medics Ne.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biotech Medics Ne assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotech Medics Ne to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.00 means that Biotech Medics Ne assets are financed with 0.4% credit (debt) and the remaining percentage (100% - 0.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotech Medics Ne:

  • The MRQ is 0.004. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.004. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.004TTM0.0040.000
TTM0.004YOY0.006-0.002
TTM0.0045Y106.826-106.822
5Y106.82610Y71.484+35.342
1.4.2. Debt to Equity Ratio

Measures if Biotech Medics Ne is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotech Medics Ne to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.4% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotech Medics Ne:

  • The MRQ is 0.004. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.004. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.004TTM0.0040.000
TTM0.004YOY0.006-0.002
TTM0.0045Y0.003+0.001
5Y0.00310Y0.008-0.005

2. Market Valuation of Biotech Medics Ne

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biotech Medics Ne generates.

  • Above 15 is considered overpriced but always compare Biotech Medics Ne to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1,291.71 means the investor is paying $-1,291.71 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotech Medics Ne:

  • The EOD is -647.655. Based on the earnings, the company is expensive. -2
  • The MRQ is -1,291.712. Based on the earnings, the company is expensive. -2
  • The TTM is -1,291.712. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-647.655MRQ-1,291.712+644.057
MRQ-1,291.712TTM-1,291.7120.000
TTM-1,291.712YOY-14.411-1,277.301
TTM-1,291.7125Y-278.864-1,012.848
5Y-278.86410Y-184.740-94.124
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotech Medics Ne:

  • The EOD is -135.416. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -270.079. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -270.079. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-135.416MRQ-270.079+134.663
MRQ-270.079TTM-270.0790.000
TTM-270.079YOY-98.922-171.157
TTM-270.0795Y-111.695-158.384
5Y-111.69510Y-80.259-31.435
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biotech Medics Ne is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Biotech Medics Ne:

  • The EOD is 0.037. Based on the equity, the company is cheap. +2
  • The MRQ is 0.073. Based on the equity, the company is cheap. +2
  • The TTM is 0.073. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.037MRQ0.073-0.036
MRQ0.073TTM0.0730.000
TTM0.073YOY0.024+0.049
TTM0.0735Y-5.287+5.360
5Y-5.28710Y-3.865-1.422
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biotech Medics Ne compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1480.1480%0.000+100%0.098+51%0.060+149%
Book Value Per Share--0.4920.4920%0.344+43%0.236+109%0.148+233%
Current Ratio--0.0000.0000%-+100%0.000+264%0.000+202%
Debt To Asset Ratio--0.0040.0040%0.006-29%106.826-100%71.484-100%
Debt To Equity Ratio--0.0040.0040%0.006-29%0.003+43%0.008-44%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0000.0000%-0.001+1947%-0.001+2085%-0.002+6125%
Free Cash Flow Per Share--0.0000.0000%0.000-38%0.000+140%-0.002+1196%
Free Cash Flow To Equity Per Share--0.1480.1480%0.000+4132145%0.124+20%0.069+115%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.051--------
Intrinsic Value_10Y_min---0.003--------
Intrinsic Value_1Y_max--0.001--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max--0.006--------
Intrinsic Value_3Y_min---0.001--------
Intrinsic Value_5Y_max--0.015--------
Intrinsic Value_5Y_min---0.002--------
Market Cap3642408.000-99%7264586.7907264586.7900%1659320.660+338%5398862.829+35%3422348.985+112%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.037-99%0.0730.0730%0.024+206%-5.287+7347%-3.865+5398%
Pe Ratio-647.655+50%-1291.712-1291.7120%-14.411-99%-278.864-78%-184.740-86%
Price Per Share0.018-99%0.0360.0360%0.008+338%0.027+35%0.017+112%
Price To Free Cash Flow Ratio-135.416+50%-270.079-270.0790%-98.922-63%-111.695-59%-80.259-70%
Price To Total Gains Ratio0.121-99%0.2420.2420%-16.993+7116%-14.526+6097%135142.274-100%
Quick Ratio--0.0000.0000%-+100%0.000+264%0.000+202%
Return On Assets--0.0000.0000%-0.002+2825%-62.484+111105119%-91.453+162615471%
Return On Equity--0.0000.0000%-0.002+2830%-0.001+2145%-0.152+269423%
Total Gains Per Share--0.1480.1480%0.000+100%0.098+51%0.060+149%
Usd Book Value--99570693.00099570693.0000%69576316.000+43%47705902.000+109%29926374.519+233%
Usd Book Value Change Per Share--0.1480.1480%0.000+100%0.098+51%0.060+149%
Usd Book Value Per Share--0.4920.4920%0.344+43%0.236+109%0.148+233%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0000.0000%-0.001+1947%-0.001+2085%-0.002+6125%
Usd Free Cash Flow---26898.000-26898.0000%-16774.000-38%-51539.600+92%-305068.543+1034%
Usd Free Cash Flow Per Share--0.0000.0000%0.000-38%0.000+140%-0.002+1196%
Usd Free Cash Flow To Equity Per Share--0.1480.1480%0.000+4132145%0.124+20%0.069+115%
Usd Market Cap3642408.000-99%7264586.7907264586.7900%1659320.660+338%5398862.829+35%3422348.985+112%
Usd Price Per Share0.018-99%0.0360.0360%0.008+338%0.027+35%0.017+112%
Usd Profit---5624.000-5624.0000%-115146.000+1947%-122880.000+2085%-350122.106+6125%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.1480.1480%0.000+100%0.098+51%0.060+149%
 EOD+2 -6MRQTTM+0 -0YOY+24 -55Y+26 -310Y+26 -3

3.2. Fundamental Score

Let's check the fundamental score of Biotech Medics Ne based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-647.655
Price to Book Ratio (EOD)Between0-10.037
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than10.004
Debt to Equity Ratio (MRQ)Less than10.004
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Biotech Medics Ne based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.831
Ma 20Greater thanMa 500.021
Ma 50Greater thanMa 1000.022
Ma 100Greater thanMa 2000.023
OpenGreater thanClose0.017
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets100,002
Total Liabilities432
Total Stockholder Equity99,571
 As reported
Total Liabilities 432
Total Stockholder Equity+ 99,571
Total Assets = 100,002

Assets

Total Assets100,002
Total Current Assets0
Long-term Assets100,002
Total Current Assets
Cash And Cash Equivalents 0
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Property Plant Equipment -13
Long-term Assets Other 15
Long-term Assets  (as reported)100,002
Long-term Assets  (calculated)2
+/- 100,000

Liabilities & Shareholders' Equity

Total Current Liabilities432
Long-term Liabilities0
Total Stockholder Equity99,571
Total Current Liabilities
Short-term Debt 27
Other Current Liabilities 405
Total Current Liabilities  (as reported)432
Total Current Liabilities  (calculated)432
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock202
Retained Earnings -1,658
Accumulated Other Comprehensive Income -202
Other Stockholders Equity 101,224
Total Stockholder Equity (as reported)99,571
Total Stockholder Equity (calculated)99,567
+/- 4
Other
Cash and Short Term Investments 0
Common Stock Shares Outstanding 202,356
Liabilities and Stockholders Equity 100,002
Net Debt 27
Net Working Capital -432
Short Long Term Debt Total 27



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312011-12-312010-12-312008-12-31
> Total Assets 
7,728
4,549
5,083
1,014
2
0
0
0
0
70,002
70,002
100,002
100,00270,00270,002000021,0145,0834,5497,728
   > Total Current Assets 
13
27
27
0
0
0
0
0
0
-1
0
0
00-1000000272713
       Cash And Cash Equivalents 
13
27
3
0
0
0
0
0
0
-1
0
0
00-100000032713
   > Long-term Assets 
0
0
0
1,014
2
0
0
0
0
70,002
70,002
100,002
100,00270,00270,002000021,014000
       Property Plant Equipment 
85
4,502
5,055
5
2
0
0
0
0
-13
-13
-13
-13-13-130000255,0554,50285
       Intangible Assets 
0
20
0
1,009
0
0
0
0
0
15
15
0
01515000001,0090200
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
15
1500000000000
> Total Liabilities 
6,663
1,553
2,023
46
46
46
46
107
187
328
426
432
432426328187107464646462,0231,5536,663
   > Total Current Liabilities 
834
1,553
2,023
46
46
46
46
107
187
328
426
432
432426328187107464646462,0231,553834
       Short-term Debt 
0
12
0
0
0
0
0
0
0
0
0
27
27000000000120
       Short Long Term Debt 
0
12
3,138
0
0
0
0
0
0
0
0
0
0000000003,138120
       Accounts payable 
41
10
17
0
0
0
0
0
0
0
0
0
000000000171041
       Other Current Liabilities 
792
1,530
1,976
46
46
46
46
107
187
328
426
405
405426328187107464646461,9761,530792
   > Long-term Liabilities 000000000000
> Total Stockholder Equity
1,065
2,996
3,060
968
-43
-46
-46
-107
-187
69,674
69,576
99,571
99,57169,57669,674-187-107-46-46-439683,0602,9961,065
   Common Stock
1,065
0
157
283
283
283
283
202
202
202
202
202
20220220220220228328328328315701,065
   Retained Earnings Total Equity000000000000
   Accumulated Other Comprehensive Income 
0
0
0
998
998
998
998
-68
1,026
71,209
71,226
-202
-20271,22671,2091,026-68998998998998000
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
3,562
3,087
-283
-283
-283
-283
863
-202
-202
-202
101,224
101,224-202-202-202863-283-283-283-2833,0873,5620



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-28
Operating Income-28-28
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense280
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-28
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6-51
EBIT - interestExpense = 0
-6
-6
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-6
Earnings Before Interest and Taxes (EBITDA)-28
 
After tax Income (+$)
Income Before Tax-6
Tax Provision-0
Net Income From Continuing Ops0-6
Net Income-6
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses28
Total Other Income/Expenses Net230
 

Technical Analysis of Biotech Medics Ne
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotech Medics Ne. The general trend of Biotech Medics Ne is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotech Medics Ne's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotech Medics Ne.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.026 < 0.029 < 0.03.

The bearish price targets are: 0.01 > 0.01 > 0.01.

Tweet this
Biotech Medics Ne Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotech Medics Ne. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotech Medics Ne Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotech Medics Ne. The current macd is -0.00180658.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biotech Medics Ne price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biotech Medics Ne. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biotech Medics Ne price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biotech Medics Ne Daily Moving Average Convergence/Divergence (MACD) ChartBiotech Medics Ne Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotech Medics Ne. The current adx is 72.95.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biotech Medics Ne shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Biotech Medics Ne Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotech Medics Ne. The current sar is 0.02110334.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biotech Medics Ne Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotech Medics Ne. The current rsi is 44.83. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Biotech Medics Ne Daily Relative Strength Index (RSI) ChartBiotech Medics Ne Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotech Medics Ne. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biotech Medics Ne price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biotech Medics Ne Daily Stochastic Oscillator ChartBiotech Medics Ne Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotech Medics Ne. The current cci is -51.89126758.

Biotech Medics Ne Daily Commodity Channel Index (CCI) ChartBiotech Medics Ne Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotech Medics Ne. The current cmo is -8.67741472.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biotech Medics Ne Daily Chande Momentum Oscillator (CMO) ChartBiotech Medics Ne Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotech Medics Ne. The current willr is -46.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biotech Medics Ne is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biotech Medics Ne Daily Williams %R ChartBiotech Medics Ne Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biotech Medics Ne.

Biotech Medics Ne Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotech Medics Ne. The current atr is 0.00570508.

Biotech Medics Ne Daily Average True Range (ATR) ChartBiotech Medics Ne Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotech Medics Ne. The current obv is -2,081,637.

Biotech Medics Ne Daily On-Balance Volume (OBV) ChartBiotech Medics Ne Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotech Medics Ne. The current mfi is 29.89.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Biotech Medics Ne Daily Money Flow Index (MFI) ChartBiotech Medics Ne Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotech Medics Ne.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Biotech Medics Ne Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotech Medics Ne based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.831
Ma 20Greater thanMa 500.021
Ma 50Greater thanMa 1000.022
Ma 100Greater thanMa 2000.023
OpenGreater thanClose0.017
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biotech Medics Ne with someone you think should read this too:
  • Are you bullish or bearish on Biotech Medics Ne? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotech Medics Ne? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotech Medics Ne

I send you an email if I find something interesting about Biotech Medics Ne.


Comments

How you think about this?

Leave a comment

Stay informed about Biotech Medics Ne.

Receive notifications about Biotech Medics Ne in your mailbox!